Babybloom Ivf And Superspeciality Hospital Private Limited
Founded in 2024 and headquartered in Haryana, India.
2024 | Gurugram, Haryana (India) | Active
Babybloom Ivf And Superspeciality Hospital Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 9 Months 7 Days
About Babybloom Ivf And Superspeciality Hospital
Babybloom Ivf And Superspeciality Hospital Private Limited (BIASHPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 May 2024 ( nine months 7 days old ). Its registered office is in Gurugram, Haryana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Pramila Gulati, Hariroop Gulati, and Pujil Gulati serve as directors at the Company.
Company Details
- Location
Gurugram, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U86909HR2024PTC121773
- Company No.
121773
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 May 2024
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Healthcare
Who are the key members and board of directors at Babybloom Ivf And Superspeciality Hospital?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pramila Gulati  | Director | 21-May-2024 | Current |
| Hariroop Gulati | Director | 21-May-2024 | Current |
| Pujil Gulati | Director | 21-May-2024 | Current |
Financial Performance of Babybloom Ivf And Superspeciality Hospital.
Enhance accessibility to Babybloom Ivf And Superspeciality Hospital's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Babybloom Ivf And Superspeciality Hospital?
Unlock access to Babybloom Ivf And Superspeciality Hospital's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Babybloom Ivf And Superspeciality Hospital?
Unlock and access historical data on people associated with Babybloom Ivf And Superspeciality Hospital, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Babybloom Ivf And Superspeciality Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Babybloom Ivf And Superspeciality Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.